Latest news
146 Giredestrant Vs Standard-of-Care Endocrine Therapy as Adjuvant Treatment for Patients With Estrogen Receptor–Positive, HER2-Negative Early Breast Cancer: Results From the Global Phase III lidERA Breast Cancer Trial - CancerNetworkCancerNetwork · Sat, 08 Aug 2026 14:00:00 GMTCells in tumour microenvironment may affect hormone treatment - Karolinska InstitutetKarolinska Institutet · Fri, 07 Aug 2026 12:46:06 GMTVepdegestrant (Veppanu) Approved by FDA - Breast Cancer.orgBreast Cancer.org · Tue, 04 Aug 2026 07:00:00 GMTFDA Green-Lights Five New Treatment Options for Breast Cancer - Cancer HealthCancer Health · Mon, 03 Aug 2026 13:01:12 GMTMaryam Lustberg: Endocrine Therapy-Related Symptom Management in Breast Cancer Care - OncodailyOncodaily · Tue, 28 Jul 2026 07:00:00 GMT